Panel Discussion: Integrated Cell Line Development — Manufacturability to GMP-Ready by Design

Manufacturing and regulatory hurdles threaten cell and gene therapy progress

The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can

Next-generation immune models: bioinks, 3D bioprinting, and future directions

International Collaboration Advances Synthetic Cell Research

The article discusses the emerging field of synthetic cell (SynCell) research, which aims to build artificial cells from molecular component

How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies

The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as

Study Shows Low-Cost Portable Biotech Tools Can Expand Access to Research and Diagnostics in Resource-Limited Settings

A global research team led by University of Toronto's Leslie Dan Faculty of Pharmacy has demonstrated the effectiveness of low-cost, portabl

Benchmarking Codon Optimization Strategies for Improved Antibody Expression

This article/webinar promotion discusses how antibody expression titers are critical for screening efficiency, developability, and manufactu